[AKER] Akers Biosciences Inc

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market Capitalization: 13.55 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 1.65 Change: 0.1 (6.13%)
Ext. hours: Change: 0 (0%)

chart AKER

Refresh chart

Strongest Trends Summary For AKER

AKER is in the long-term down -90% below S&P in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Akers Biosciences, Inc., together with its subsidiaries, focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. The company offers BreathScan/CHUBE, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor weight loss; VIVO for the measurement of biological markers for oxidative stress that relates to cellular damage non-invasively; PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid assay for detecting heparin-induced thrombocytopenia antibodies; seraSTAT, a device to separate rapid blood cells; and Tri-Cholesterol ?Check? to estimate high density lipoprotein cholesterol and low density lipo protein levels. It is also involved in the development of Breath Ketone ?Check?, a disposable breath ketone device for diabetic monitoring, and management of senile dementia and alzheimers disease patients; Breath PulmoHe

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding5.42 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -62.31% Sales Growth - Q/Q-64.75% P/E
P/E To EPS Growth P/S3.6 P/BV0.95 Price/Cash Per Share1.61
Price/Free Cash Flow-3.47 ROA-25.08% ROE-27.12% ROI
Current Ratio10.26 Quick Ratio9.42 Long Term Debt/Equity Debt Ratio0.08
Gross Margin78.85% Operating Margin-105% Net Profit Margin-102.39% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities Cash From Operating Activities1.12 M Gross Profit280 K
Net Profit-1.24 M Operating Profit-1.36 M Total Assets15.36 M Total Current Assets11.81 M
Total Current Liabilities1.15 M Total Debt Total Liabilities1.15 M Total Revenue510 K
Technical Data
High 52 week3.76 Low 52 week0.13 Last close1.47 Last change13.08%
RSI77.33 Average true range0.22 Beta1.44 Volume16.56 K
Simple moving average 20 days32.34% Simple moving average 50 days-3.02% Simple moving average 200 days22.91%
Performance Data
Performance Week2.08% Performance Month26.72% Performance Quart-50.34% Performance Half208.69%
Performance Year91.16% Performance Year-to-date30.09% Volatility daily12.57% Volatility weekly28.11%
Volatility monthly57.61% Volatility yearly199.57% Relative Volume179.39% Average Volume2.17 M
New High New Low

News

2019-05-20 17:38:54 | Akers Biosciences Reports Q1 2019 Earnings

2019-04-02 14:15:30 | As losses mount, medical device maker continues pursuit of 'strategic alternatives'

2019-04-01 17:31:34 | Akers Biosciences Reports Fiscal Year 2018 Earnings

2019-03-28 08:02:46 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-02-22 07:20:00 | Factors of Influence in 2019, Key Indicators and Opportunity within ARRIS International plc, Edwards Lifesciences, DENTSPLY SIRONA, Vail Resorts, Akers Biosciences, and DURECT — New Research Emphasizes Economic Growth

2019-02-19 08:01:57 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-02-16 08:05:31 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-02-08 08:05:39 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-02-05 08:05:45 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-01-31 08:04:57 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-01-17 08:02:09 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-01-15 08:04:54 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2019-01-09 08:05:01 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-12-31 10:50:00 | 4 Healthcare Stocks That Are Raising Eyebrows

2018-12-28 11:45:00 | These 4 Healthcare Stocks Are Heating Up

2018-11-30 08:30:00 | Market Trends Toward New Normal in Gartner, CONVERGEONE HLD, Syros Pharmaceuticals, Akers Biosciences, Edge Therapeutics, and Cracker Barrel Old Country Store — Emerging Consolidated Expectations, Analyst Ratings

2018-11-29 08:06:42 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-11-20 15:09:56 | This Tiny Biotech Firm Is Weighing An Entrance Into Cannabis

2018-11-20 08:06:47 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-11-20 06:50:00 | Today’s Research Reports on Stocks to Watch: Akers Biosciences and Align Technology

2018-11-19 16:48:05 | [$$] Biotech Learns the Magic Word

2018-11-19 14:34:49 | Apple shares down after cutting production orders for all three iphone models

2018-11-19 13:59:00 | Failing biotech company mentions pot business, stock soars 70%

2018-11-19 10:23:45 | South Jersey medical device firm exploring cannabis industry combination

2018-11-19 09:01:06 | Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry

2018-11-15 07:00:00 | Akers Biosciences Announces Q3 2018 Earnings

2018-11-07 13:16:43 | South Jersey medical-device company exploring 'strategic alternatives'

2018-11-07 09:15:00 | Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value

2018-10-26 08:05:25 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-10-25 08:06:14 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-10-23 08:06:46 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-10-23 07:40:00 | Market Trends Toward New Normal in PTC Therapeutics, AeroVironment, Autodesk, Coca-Cola Bottling Co. Consolidated, Akers Biosciences, and TEGNA — Emerging Consolidated Expectations, Analyst Ratings

2018-10-13 08:06:32 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-10-08 12:08:10 | South Jersey medical device company makes CEO switch, settles lawsuit

2018-10-08 02:00:00 | Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update

2018-09-29 08:05:20 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-09-27 08:06:48 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-09-25 08:06:36 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-09-20 08:05:48 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-08-21 08:20:00 | Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy — Emerging Consolidated Expectations, Analyst Ratings

2018-08-14 16:18:00 | Akers Biosciences Announces Q2 and H1 2018 Earnings

2018-08-14 08:06:55 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.

2018-08-13 12:05:00 | DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2018-08-13 10:21:00 | FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. AKER & Lead Plaintiff Deadline: August 13, 2018

2018-08-12 21:40:00 | DEADLINE MONDAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2018-08-12 11:00:00 | AKER AUG 13 DEADLINE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First Filed Case – AKER

2018-08-11 09:00:00 | ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER

2018-08-11 08:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – AKER

2018-08-10 19:42:00 | The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. AKER

2018-08-10 12:50:00 | AUGUST 13 DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm